Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine
Wang, M.C.; Sharma, R.A.; Bloch, A.
Cancer Research 33(6): 1265-1271
1973
ISSN/ISBN: 0008-5472 PMID: 4578070 Document Number: 65878
Document emailed within 1 workday
Related Documents
Csányi, E.; Elekes, I. 1972: Studies on the mode of action of the cytostatic 1,4-di-mesyloxyethylamino-1,4-dideoxy-m-erythritol (R-74) Neoplasma 19(3): 189-198Kalman, T.I.; Bardos, T.J. 1970: Enzymatic studies relating to the mode of action of 5-mercapto-2'-deoxyuridine Molecular Pharmacology 6(6): 621-630
Corwin, L.M.; Gordon, R.K.; Shloss, J. 1981: Studies of the mode of action of vitamin e in stimulating T-cell mitogenesis Scandinavian Journal of Immunology 14(5): 565-571
Eisner, M.; Shalev, E.; Amrein, R.; Ferrat, E. 1976: On the mode of action of difenoxin (R 15 403). Part 2: Studies on the perfused isolated colonic loop of the rat Arzneimittel-Forschung 26(10): 1842-1849
Fontaine, L.; Grand, M.; Molho, D.; Boschetti, E. 1968: Spasmolytic activity of 4-methylumbelliferone on Oddi's sphincter. Studies on the mode of action of the drug Therapie 23(1): 63-74
Ho, Y.K. 1979: Studies on the mode of action of partially thiolated polycytidylic acid (MPC), a novel type of antineoplastic agent Research Communications in Chemical Pathology and Pharmacology 25(2): 293-306
Schneyer, C.A.; Galbraith, W.M. 1975: Evaluation of sialogogic action of cyclocytidine (NSC-145668) and anhydro-ara-5-fluorocytidine (NSC-166641) Cancer ChemoTherapy Reports 59(5): 1019
Hoovis, M.L.; Chu, M.Y. 1973: Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y) Cancer Research 33(3): 521-525
Oh-ishi, J.; Kataoka, T.; Tsukagoshi, S.; Sakurai, Y.; Shibukawa, M.; Kobayashi, H. 1981: Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance Cancer Research 41(6): 2501-2506
Maehara, Y.; Kusumoto, T.; Sakaguchi, Y.; Kusumoto, H.; Anai, H.; Sugimachi, K. 1989: Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in Hela cells Anticancer Research 9(1): 41-44
Momparler, R.L. 1972: Kinetic and template studies with 1- -D-arabinofuranosylcytosine 5'-triphosphate and mammalian deoxyribonucleic acid polymerase Molecular Pharmacology 8(3): 362-370
Szekeres, L.; Koltai, M.; Pataricza, J.; Takáts, I.; Udvary, E. 1984: On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action Biomedica Biochimica Acta 43(8-9): S135-S142
Kreis, W.; Wechter, W.J. 1972: Studies on drug resistance. IV. Synthesis and biological activities of 1- -D-arabinofuranosylcytosine 3',5'-cyclic monophosphate and a derivative Research Communications in Chemical Pathology and Pharmacology 4(3): 631-640
Takashina, J. 1956: Studies on action mechanisms of antituberculous drugs. I. Studies on inhibitory action of SM, PAS, INH against BCG dehydrogenase Science Reports of the Research Institutes, Tohoku University, Series C: Medicine 7(2): 187-194
Gounot, A.M.; Brevet, C.; Videz, S. 1979: Nitrofurans: mode of action Annales Pharmaceutiques Francaises 37(9-10): 421-428
Grobecker, H.; Grobecker, H. 1976: On the mode of action of heptaminol Arzneimittel-Forschung 26(12): 2167-2171
Leonard, B.E. 1982: On the mode of action of mianserin Advances in Biochemical Psychopharmacology 31: 301-319
Benedikt, O. 1975: The mode of action of trabeculectomy Klinische Monatsblatter für Augenheilkunde 167(5): 679-685
Lorrain, J.M. 1972: Mode of action of antibiotics Bordeaux Medical 5(4): 335-342
Natale, F. 1980: Fusafungin: tolerance and mode of action Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 35(4): 185-192